1. Home
  2. EVV vs VIR Comparison

EVV vs VIR Comparison

Compare EVV & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Limited Duration Income Fund of Beneficial Interest

EVV

Eaton Vance Limited Duration Income Fund of Beneficial Interest

HOLD

Current Price

$9.93

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$7.21

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVV
VIR
Founded
2003
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
EVV
VIR
Price
$9.93
$7.21
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$28.63
AVG Volume (30 Days)
323.7K
1.9M
Earning Date
01-01-0001
02-25-2026
Dividend Yield
9.66%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$16,860,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.52
$4.16
52 Week High
$10.07
$10.67

Technical Indicators

Market Signals
Indicator
EVV
VIR
Relative Strength Index (RSI) 48.98 53.96
Support Level $9.88 $6.86
Resistance Level $9.93 $7.97
Average True Range (ATR) 0.04 0.50
MACD 0.00 -0.03
Stochastic Oscillator 57.05 64.40

Price Performance

Historical Comparison
EVV
VIR

About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest

Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: